A systematic review of the safety of lisdexamfetamine dimesylate.
about
Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of EfficacyCardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.Sleep Problems in Children with Attention Deficit/Hyperactivity Disorder: Current Status of Knowledge and Appropriate Management.Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe.Alternative pharmacological strategies for adult ADHD treatment: a systematic review.Lisdexamfetamine: A Review in ADHD in Adults.Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain.A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK.Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review.Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers.Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects.Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder.DSM-5 Changes in Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder: Implications for Comorbid Sleep Issues.Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate.Adult Attention-Deficit/Hyperactivity Disorder (ADHD) and Insomnia: an Update of the Literature.Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD.Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study.
P2860
Q26750486-B0943EFF-0B10-4F75-97AE-73B437E483C2Q30399107-2D4AD512-B3D5-4528-BDE4-6E6D35FE8BFEQ34677664-89A562BC-A438-437B-B290-8BBF0A6B609FQ38374695-5E855FCE-CD43-4B07-87F9-FCB3FFB2ACC4Q38676199-C53381F5-6E55-4AA4-83D4-6976453DAEE5Q38799006-7178E603-E9BD-4ABC-8476-3862785D2436Q38799636-75D167AD-FFBE-4424-9305-AD943BD9D90CQ39017592-AEE5CE93-D239-4A3A-B85C-53FCEEE6F723Q39043767-4165D4A3-03CF-4379-B5CF-8F7605E5E83EQ41127210-C078C826-90CB-4AF9-B448-14A86FC7D8A4Q41312831-96DAC8B5-6E55-4DFE-8AD5-2E06263576B8Q41522057-2A6ABC2C-C046-49D4-8EB1-457DAB1DE1D7Q41552466-FE409F63-4EC3-4FB8-A942-15CFBF71FDCDQ47550500-BBF9B734-853E-45A1-BD75-96CF2F991422Q47667525-ED5B1A67-32C8-44EA-869C-B5A25750BD0DQ47677209-E26618B2-AEE5-41D6-B36C-3D43209C7CA1Q48194563-02C39B1B-63EC-4E23-94DA-3D5E1E9873C2
P2860
A systematic review of the safety of lisdexamfetamine dimesylate.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A systematic review of the safety of lisdexamfetamine dimesylate.
@ast
A systematic review of the safety of lisdexamfetamine dimesylate.
@en
type
label
A systematic review of the safety of lisdexamfetamine dimesylate.
@ast
A systematic review of the safety of lisdexamfetamine dimesylate.
@en
prefLabel
A systematic review of the safety of lisdexamfetamine dimesylate.
@ast
A systematic review of the safety of lisdexamfetamine dimesylate.
@en
P2093
P2860
P921
P1433
P1476
A systematic review of the safety of lisdexamfetamine dimesylate
@en
P2093
Beatriz Caballero
Richard Civil
Shaw Sorooshian
P2860
P2888
P304
P356
10.1007/S40263-014-0166-2
P577
2014-06-01T00:00:00Z